DUDLEY BENNETT
Allopathic & Osteopathic Physicians|Internal Medicine WARWICK, RI NPI 1730185570
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine RI Amgen Inc. All categories
General Payments — all program years on this page
$1,212.54
- Category: General Payments
- Program years: PY2018–2020
- Record count: 67
- As of (CMS publication): 2026-01-23
Latest program year (PY2020): $128.99 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2020) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $128.99 | 7 |
By paying entity
Latest program year (PY2020) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $40.80 | 2 |
| Lilly USA, LLC | $20.89 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.97 | 1 |
| UCB, Inc. | $18.80 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.15 | 1 |
| Merck Sharp & Dohme Corporation | $14.38 | 1 |
By program year
Records — PY2020 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 727815247 | E.R. Squibb & Sons, L.L.C. | $18.97 | 02/20/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 728424477 | Lilly USA, LLC | $20.89 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741017115 | Amgen Inc. | $20.50 | 01/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 741017119 | Amgen Inc. | $20.30 | 03/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 746069001 | UCB, Inc. | $18.80 | 01/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 747132401 | Takeda Pharmaceuticals U.S.A., Inc. | $15.15 | 02/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 747616733 | Merck Sharp & Dohme Corporation | $14.38 | 02/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.